News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celator Pharmaceuticals, Inc. Granted U.S. Patent Covering Lead Cancer Product


9/21/2011 10:46:35 AM

PRINCETON, N.J.--(BUSINESS WIRE)--Celator Pharmaceuticals today announced that U.S. Patent No. 8,022,279 was issued by the United States Patent and Trademark Office on September 20, 2011 and that two related patents in Japan have been granted as well. These patents add to the intellectual property surrounding Celator’s lead anti-leukemia drug, CPX-351.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES